Oral lichen planus and oral lichenoid lesions

diagnostic and therapeutic considerations

Ibtisam Al-Hashimi, Mark Schifter, Peter B. Lockhart, David Wray, Michael Brennan, Cesar Migliorati, Tony Axéll, Alison J. Bruce, William Carpenter, Ellen Eisenberg, Joel B. Epstein, Palle Holmstrup, Mats Jontell, Francina Lozada-Nur, Raj Nair, Bud Silverman, Kobkan Thongprasom, Martin Thornhill, Saman Warnakulasuriya, Isaäc van der Waal

Research output: Contribution to journalArticle

258 Citations (Scopus)

Abstract

Several therapeutic agents have been investigated for the treatment of oral lichen planus (OLP). Among these are corticosteroids, retinoids, cyclosporine, and phototherapy, in addition to other treatment modalities. A systematic review of clinical trials showed that particularly topical corticosteroids are often effective in the management of symptomatic OLP lichen planus. Systemic corticosteroids should be only considered for severe widespread OLP and for lichen planus involving other mucocutaneous sites. Because of the ongoing controversy in the literature about the possible premalignant character of OLP, periodic follow-up is recommended. There is a spectrum of oral lichen planus-like ("lichenoid") lesions that may confuse the differential diagnosis. These include lichenoid contact lesions, lichenoid drug reactions and lichenoid lesions of graft-versus-host disease. In regard to the approach to oral lichenoid contact lesions the value of patch testing remains controversial. Confirmation of the diagnosis of an oral lichenoid drug reaction may be difficult, since empiric withdrawal of the suspected drug and/or its substitution by an alternative agent may be complicated. Oral lichenoid lesions of graft-versus-host disease (OLL-GVHD) are recognized to have an association with malignancy. Local therapy for these lesions rests in topical agents, predominantly corticosteroids.

Original languageEnglish (US)
Pages (from-to)S25.e1-S25.e12
JournalOral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology
Volume103
Issue numberSUPPL.
DOIs
StatePublished - Jan 1 2007

Fingerprint

Oral Lichen Planus
Adrenal Cortex Hormones
Lichen Planus
Graft vs Host Disease
Pharmaceutical Preparations
Therapeutics
Oral Diagnosis
Phototherapy
Retinoids
Cyclosporine
Differential Diagnosis
Clinical Trials
Neoplasms

All Science Journal Classification (ASJC) codes

  • Surgery
  • Oral Surgery
  • Otorhinolaryngology
  • Dentistry(all)

Cite this

Al-Hashimi, I., Schifter, M., Lockhart, P. B., Wray, D., Brennan, M., Migliorati, C., ... van der Waal, I. (2007). Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, 103(SUPPL.), S25.e1-S25.e12. https://doi.org/10.1016/j.tripleo.2006.11.001

Oral lichen planus and oral lichenoid lesions : diagnostic and therapeutic considerations. / Al-Hashimi, Ibtisam; Schifter, Mark; Lockhart, Peter B.; Wray, David; Brennan, Michael; Migliorati, Cesar; Axéll, Tony; Bruce, Alison J.; Carpenter, William; Eisenberg, Ellen; Epstein, Joel B.; Holmstrup, Palle; Jontell, Mats; Lozada-Nur, Francina; Nair, Raj; Silverman, Bud; Thongprasom, Kobkan; Thornhill, Martin; Warnakulasuriya, Saman; van der Waal, Isaäc.

In: Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, Vol. 103, No. SUPPL., 01.01.2007, p. S25.e1-S25.e12.

Research output: Contribution to journalArticle

Al-Hashimi, I, Schifter, M, Lockhart, PB, Wray, D, Brennan, M, Migliorati, C, Axéll, T, Bruce, AJ, Carpenter, W, Eisenberg, E, Epstein, JB, Holmstrup, P, Jontell, M, Lozada-Nur, F, Nair, R, Silverman, B, Thongprasom, K, Thornhill, M, Warnakulasuriya, S & van der Waal, I 2007, 'Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations', Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, vol. 103, no. SUPPL., pp. S25.e1-S25.e12. https://doi.org/10.1016/j.tripleo.2006.11.001
Al-Hashimi, Ibtisam ; Schifter, Mark ; Lockhart, Peter B. ; Wray, David ; Brennan, Michael ; Migliorati, Cesar ; Axéll, Tony ; Bruce, Alison J. ; Carpenter, William ; Eisenberg, Ellen ; Epstein, Joel B. ; Holmstrup, Palle ; Jontell, Mats ; Lozada-Nur, Francina ; Nair, Raj ; Silverman, Bud ; Thongprasom, Kobkan ; Thornhill, Martin ; Warnakulasuriya, Saman ; van der Waal, Isaäc. / Oral lichen planus and oral lichenoid lesions : diagnostic and therapeutic considerations. In: Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology. 2007 ; Vol. 103, No. SUPPL. pp. S25.e1-S25.e12.
@article{984c75861c504eab848979b0c4357e3f,
title = "Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations",
abstract = "Several therapeutic agents have been investigated for the treatment of oral lichen planus (OLP). Among these are corticosteroids, retinoids, cyclosporine, and phototherapy, in addition to other treatment modalities. A systematic review of clinical trials showed that particularly topical corticosteroids are often effective in the management of symptomatic OLP lichen planus. Systemic corticosteroids should be only considered for severe widespread OLP and for lichen planus involving other mucocutaneous sites. Because of the ongoing controversy in the literature about the possible premalignant character of OLP, periodic follow-up is recommended. There is a spectrum of oral lichen planus-like ({"}lichenoid{"}) lesions that may confuse the differential diagnosis. These include lichenoid contact lesions, lichenoid drug reactions and lichenoid lesions of graft-versus-host disease. In regard to the approach to oral lichenoid contact lesions the value of patch testing remains controversial. Confirmation of the diagnosis of an oral lichenoid drug reaction may be difficult, since empiric withdrawal of the suspected drug and/or its substitution by an alternative agent may be complicated. Oral lichenoid lesions of graft-versus-host disease (OLL-GVHD) are recognized to have an association with malignancy. Local therapy for these lesions rests in topical agents, predominantly corticosteroids.",
author = "Ibtisam Al-Hashimi and Mark Schifter and Lockhart, {Peter B.} and David Wray and Michael Brennan and Cesar Migliorati and Tony Ax{\'e}ll and Bruce, {Alison J.} and William Carpenter and Ellen Eisenberg and Epstein, {Joel B.} and Palle Holmstrup and Mats Jontell and Francina Lozada-Nur and Raj Nair and Bud Silverman and Kobkan Thongprasom and Martin Thornhill and Saman Warnakulasuriya and {van der Waal}, Isa{\"a}c",
year = "2007",
month = "1",
day = "1",
doi = "10.1016/j.tripleo.2006.11.001",
language = "English (US)",
volume = "103",
pages = "S25.e1--S25.e12",
journal = "Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology",
issn = "2212-4403",
publisher = "Elsevier USA",
number = "SUPPL.",

}

TY - JOUR

T1 - Oral lichen planus and oral lichenoid lesions

T2 - diagnostic and therapeutic considerations

AU - Al-Hashimi, Ibtisam

AU - Schifter, Mark

AU - Lockhart, Peter B.

AU - Wray, David

AU - Brennan, Michael

AU - Migliorati, Cesar

AU - Axéll, Tony

AU - Bruce, Alison J.

AU - Carpenter, William

AU - Eisenberg, Ellen

AU - Epstein, Joel B.

AU - Holmstrup, Palle

AU - Jontell, Mats

AU - Lozada-Nur, Francina

AU - Nair, Raj

AU - Silverman, Bud

AU - Thongprasom, Kobkan

AU - Thornhill, Martin

AU - Warnakulasuriya, Saman

AU - van der Waal, Isaäc

PY - 2007/1/1

Y1 - 2007/1/1

N2 - Several therapeutic agents have been investigated for the treatment of oral lichen planus (OLP). Among these are corticosteroids, retinoids, cyclosporine, and phototherapy, in addition to other treatment modalities. A systematic review of clinical trials showed that particularly topical corticosteroids are often effective in the management of symptomatic OLP lichen planus. Systemic corticosteroids should be only considered for severe widespread OLP and for lichen planus involving other mucocutaneous sites. Because of the ongoing controversy in the literature about the possible premalignant character of OLP, periodic follow-up is recommended. There is a spectrum of oral lichen planus-like ("lichenoid") lesions that may confuse the differential diagnosis. These include lichenoid contact lesions, lichenoid drug reactions and lichenoid lesions of graft-versus-host disease. In regard to the approach to oral lichenoid contact lesions the value of patch testing remains controversial. Confirmation of the diagnosis of an oral lichenoid drug reaction may be difficult, since empiric withdrawal of the suspected drug and/or its substitution by an alternative agent may be complicated. Oral lichenoid lesions of graft-versus-host disease (OLL-GVHD) are recognized to have an association with malignancy. Local therapy for these lesions rests in topical agents, predominantly corticosteroids.

AB - Several therapeutic agents have been investigated for the treatment of oral lichen planus (OLP). Among these are corticosteroids, retinoids, cyclosporine, and phototherapy, in addition to other treatment modalities. A systematic review of clinical trials showed that particularly topical corticosteroids are often effective in the management of symptomatic OLP lichen planus. Systemic corticosteroids should be only considered for severe widespread OLP and for lichen planus involving other mucocutaneous sites. Because of the ongoing controversy in the literature about the possible premalignant character of OLP, periodic follow-up is recommended. There is a spectrum of oral lichen planus-like ("lichenoid") lesions that may confuse the differential diagnosis. These include lichenoid contact lesions, lichenoid drug reactions and lichenoid lesions of graft-versus-host disease. In regard to the approach to oral lichenoid contact lesions the value of patch testing remains controversial. Confirmation of the diagnosis of an oral lichenoid drug reaction may be difficult, since empiric withdrawal of the suspected drug and/or its substitution by an alternative agent may be complicated. Oral lichenoid lesions of graft-versus-host disease (OLL-GVHD) are recognized to have an association with malignancy. Local therapy for these lesions rests in topical agents, predominantly corticosteroids.

UR - http://www.scopus.com/inward/record.url?scp=33947217401&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947217401&partnerID=8YFLogxK

U2 - 10.1016/j.tripleo.2006.11.001

DO - 10.1016/j.tripleo.2006.11.001

M3 - Article

VL - 103

SP - S25.e1-S25.e12

JO - Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

JF - Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

SN - 2212-4403

IS - SUPPL.

ER -